MAM
QTTB icon

Monaco Asset Management’s Q32 Bio QTTB Stock Holding History

Monaco Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,919
Closed -$169K – 99
2025
Q4 		$169K Sell
50,919
-260,218
-84% -$735K 0.03% 78
2025
Q3 		$616K Sell
311,137
-280,800
-47% -$540K 0.04% 77
2025
Q2 		$882K Buy
591,937
+86,486
+17% +$147K 0.15% 72
2025
Q1 		$834K Sell
505,451
-69,365
-12% -$187K 0.17% 56
2024
Q4 		$1.98M Buy
+574,816
New +$18.2M 0.29% 41

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Monaco Asset Management's QTTB Position: Q1 2026 in Review

Monaco Asset Management sold out of Q32 Bio (QTTB) in Q1 2026, closing a stake of 50,919 shares — an estimated $169K sold.

Monaco Asset Management first reported a position in QTTB in Q4 2024 and held it in 5 quarters. The position peaked at $1.98M in Q4 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Monaco Asset Management reported no remaining Q32 Bio position as of Q1 2026 after selling out during the quarter.
  • Monaco Asset Management sold 50,919 Q32 Bio shares in Q1 2026, an estimated $169K.
  • Monaco Asset Management first reported a position in Q32 Bio in Q4 2024 and held it in 5 quarters.
  • Monaco Asset Management's Q32 Bio position peaked at $1.98M in Q4 2024.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Monaco Asset Management's 13F filing for Q1 2026, filed 11 May 2026.